The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease

The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease

The increasing number of patients with fatty liver disease is a major health problem. Fatty liver disease with metabolic dysfunction has been recognized as nonalcoholic fatty liver disease (NAFLD). Although there is no standard therapy for NAFLD, previous reports support the effect of sodium-glucose...

Full description

Bibliographic Details
Main Authors: Takeshi Goya, Koji Imoto, Shigeki Tashiro, Tomomi Aoyagi, Motoi Takahashi, Miho Kurokawa, Hideo Suzuki, Masatake Tanaka, Masaki Kato, Motoyuki Kohjima, Yoshihiro Ogawa
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Gastroenterology Insights
Subjects:
MAFLD
fatty liver
SGLT2 inhibitor
type 2 diabetes mellitus
body composition
Online Access:https://www.mdpi.com/2036-7422/13/1/3

Similar Items

Similar Items